Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hong Tian
Observed name:
H Tian
Institutions:
Soochow University,
First Affiliated Hospital of Soochow University
Observed institutions:
Soochow University,
First Affiliated Hospital of Soochow University,
State Key Laboratory of Radiation Medicine and Protection
ORCID:
0000-0001-7151-6416
Observed ORCID:
0000-0001-7151-6416
OpenAlex ID:
A5050333086
Bortezomib, a promising alternative for patients with refractory or relapsed thrombotic thrombocytopenic purpura after rituximab treatment
2022
·
Jie Yin
, Hong Tian
, et al.
·
British Journal of Haematology
·
13
Real‐world evidence of avatrombopag for the treatment of immune thrombocytopenia intolerant or ineffective to eltrombopag/hetrombopag
2024
·
Hong Tian
, Lu Zhou
, et al.
·
British Journal of Haematology
·
9
Developing a Framework of Entrustable Professional Activities for Residency Training in Hematology
2025
·
Hong Tian
, Lan Xu
, et al.
·
Advances in Medical Education and Practice
·
1
[A combined regimen based on bortezomib and glucocorticoids for 6 patients with recurrent/refractory immune thrombotic thrombocytopenic purpura].
2023
·
J Yin
, H Tian
, et al.
·
PubMed Central
·
1
PDF
[Clinical diagnosis and treatment of hereditary thrombocytopenia and purpura: a report of five cases and literature review].
2023
·
X P Lyu
, J Yin
, et al.
·
PubMed Central
·
1
PDF
Combination of Thrombopoietin Receptor Agonists and Rituximab in Relapsed/Refractory Immune Thrombocytopenia: A Multicenter Real-World Study
2026
·
Hong Tian
, Xuewen Song
, et al.
·
Journal of Thrombosis and Haemostasis
Show more works
View as search
Works count:
6
Citation count:
25
H-index:
2
I10-index:
1
Year
Topic
Type